CORALAB logo

Coral Laboratories Ltd

CORALAB·BSE·
574.00 -11.00 (-1.88%)
Market Cap209.39 Cr
PE Ratio8.49
Volume943
Day High - Low606.95 - 574.00
52W High-Low679.00 - 360.00
DocStoX Score
5.6/10
Fair
Fair Value
Sign in to see
ROE
7.88%
Weak
P/E
8.49x
Cheap
Debt / Equity
0.02
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Fair

Price performance

Day574.00
606.95
52W360.00
679.00
DocStoX take

Supported by momentum (7.4) and valuation (6.8), but held back by growth (2.4).

DocStoX score

Low confidence
5.6
/10
Fair
Quality
Solid
ROE 7.9%
Valuation
Fair
P/E 8.5×
Growth
Flat
Revenue -2.4% 5Y CAGR
Risk
Moderate
D/E 0.02
Momentum
Firm
67% of 52-week range

At a glance

Market Cap
₹209 Cr
52W High / Low
₹679 / ₹360
Dividend Yield
0.31%
Promoter Holding
71.51%
EPS (TTM)
₹67.63
Book Value
₹585.74

Key highlights

  • Low leverage — D/E 0.02
  • Profitable in all of the last 5 years
  • Undemanding at 8× earnings
  • Revenue shrinking 2% a year
  • Growth is weak (2.4/10)
4 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Coral Laboratories Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Coral Laboratories Ltd (CORALAB) Share Price at ₹574 (-1.88%) | DocStoX